Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-026941
Filing Date
2024-11-15
Accepted
2024-11-15 16:04:55
Documents
2
Period of Report
2024-11-13

Document Format Files

Seq Description Document Type Size
1 form3-11152024_091150.html 3  
1 form3-11152024_091150.xml 3 5383
2 ex24-11152024_091151.htm EX-24 5442
  Complete submission text file 0001415889-24-026941.txt   12570
Mailing Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037
Business Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037 858-952-5500
CalciMedica, Inc. (Issuer) CIK: 0001534133 (see all company filings)

EIN.: 452120079 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ATAI LIFE SCIENCES N.V. KRAUSENSTRASSE 9-10 BERLIN 2M 10117
Business Address
Bardin Stephen (Reporting) CIK: 0001942596 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39538 | Film No.: 241467765